Ziprasidone augmentation of escitalopram for major depressive disorder: Cardiac, endocrine, metabolic, and motoric effects in a randomized, double-blind, placebo-controlled study

David Mischoulon, Richard C. Shelton, Lee Baer, William V. Bobo, Laura Curren, Maurizio Fava, George I. Papakostas

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Ziprasidone augmentation of escitalopram for major depressive disorder: Cardiac, endocrine, metabolic, and motoric effects in a randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences